Host-Response Diagnostics

Delivering precision medicine on demand


TEDx Palo Alto:
The power of reading the immune system to better diagnose disease

Dr. Tim Sweeney, Inflammatix Co-Founder and CEO

Our tests are addressing significant clinical needs in acute infection and sepsis diagnosis that affect millions of people


In the News: Game Changing Impact

Recent notable news stories

January 10, 2020

New Technologies Can Step Up Fight Against Antimicrobial Resistance and Sepsis

Link to story

January 10, 2020

Inflammatix raises $32M, plus a BARDA contract, for its point-of-care infection diagnostics

Link to story

December 4, 2019

Genetic platform takes the guesswork out of catching infections

Link to story

November 15, 2019

Inflammatix Nabs $6M from BARDA to Develop POC Acute Infection Diagnostic

Link to story

Also covered by


Stay in touch with Twitter updates: Find out the latest news.

Connect with Twitter